Changjiang Pharmaceutical Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 470.43 million compared to CNY 988.65 million a year ago. Revenue was CNY 476.01 million compared to CNY 991.85 million a year ago.

Net loss was CNY 24.22 million compared to CNY 40.28 million a year ago. Basic loss per share from continuing operations was CNY 0.0691 compared to CNY 0.115 a year ago. Diluted loss per share from continuing operations was CNY 0.0691 compared to CNY 0.115 a year ago.